New REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl) Associated with 29 Percent Relative ...

-- Analysis Also Found IPE Was Associated with a 41% Reduction in Total Events Compared with Placebo --

Related Keywords

United Kingdom ,Netherlands ,Denmark ,China ,Dublin ,Ireland ,Austria ,Lebanon ,United States ,New Jersey ,Sweden ,Spain ,Finland ,Philadelphia ,Pennsylvania ,United Arab Emirates ,Canada ,Switzerland ,Americans ,Great Britain ,Scotland ,American ,Mark Marmur ,Clin Cardiol ,Coll Cardiol ,A Report From The American Heart Association ,European Union ,Drug Administration ,American Heart Association ,Amarin Corporation ,Nasdaq ,Exchange Commission ,Also Found ,Total Events Compared ,Almost Exclusively Comprised ,Established Cardiovascular ,Scientific Data ,Clinical Use ,Reduce Cardiovascular ,Presented Today ,Scientific Sessions ,Simultaneously Published ,European Heart Journal ,Metabolic Syndrome ,United Arab ,Private Securities Litigation Reform Act ,Securities Act ,Clinic Metabolic Syndrome ,Its Individual Components ,Renal Function ,Heart Disease ,Stroke Statistics ,Report From ,American Heart ,Cardiovascular Events ,Icosapent Ethyl ,Cardiovascular Risk Reduction ,Total Ischemic Events ,Region ,